Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DIS vs MRNA✓SelectedUSD · MRNADIS vs MRNA performance historyLatest closeAs of-1.72%11/19
Stock and ETF performance explorer

DIS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+12.1%
MRNA return
+806.0%
Excess return
-793.9%
Maximum drawdown
-60.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.7%+1.3%-3.0%-1.8%
7D+1.7%-13.8%+15.5%+2.2%
30D+7.7%-17.7%+25.3%+8.3%
3M+12.5%+14.3%-1.9%+11.4%
6M+18.5%+336.0%-317.5%+8.5%
YTD+6.5%+575.9%-569.4%-4.7%
1Y+16.5%+724.4%-707.8%+3.3%
3Y+31.7%+160.8%-129.0%+20.0%
5Y-19.5%-24.4%+5.0%-26.0%
All+12.1%+806.0%-793.9%+5.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling